1.Hyysalo, J, Mannisto, VT, Zhou, Y, et al. (2014) A population-based study on the prevalence of NASH using scores validated against liver histology. J Hepatol 60, 839–846.
2.Ratziu, V, Goodman, Z & Sanyal, A (2015) Current efforts and trends in the treatment of NASH. J Hepatol 62, 1 Suppl., S65–S75.
3.Byrne, CD & Targher, G (2015) NAFLD: a multisystem disease. J Hepatol 62, S47–S64.
4.Marra, F & Svegliati-Baroni, G (2018) Lipotoxicity and the gut–liver axis in NASH pathogenesis. J Hepatol 68, 280–295.
5.Bae, M, Park, YK & Lee, JY (2017) Food components with antifibrotic activity and implications in prevention of liver disease. J Nutr Biochem 55, 1–11.
6.Samoggia, A & Riedel, B (2018) Coffee consumption and purchasing behavior review: insights for further research. Appetite 129, 70–81.
7.Poole, R, Kennedy, OJ, Roderick, P, et al. (2017) Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. Br Med J 359, j5024.
8.Xiao, Q, Sinha, R, Graubard, BI, et al. (2014) Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999–2010. Hepatology 60, 2091–2098.
9.Dickson, JC, Liese, AD, Lorenzo, C, et al. (2015) Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study. BMC Gastroenterol 15, 88–97.
10.Kennedy, OJ, Roderick, P, Buchanan, R, et al. (2017) Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis. BMJ Open 7, e013739.
11.Salomone, F, Galvano, F & Li Volti, G (2017) Molecular bases underlying the hepatoprotective effects of coffee. Nutrients 9, E85.
12.Assy, N, Nasser, G, Kamayse, I, et al. (2008) Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 22, 811–816.
13.Alferink, LJM, Kiefte-de Jong, JC & Darwish Murad, S (2018) Potential mechanisms underlying the role of coffee in liver health. Semin Liver Dis 38, 193–214.
14.Vitaglione, P, Fogliano, V & Pellegrini, N (2012) Coffee, colon function and colorectal cancer. Food Funct 3, 916–922.
15.De Filippis, F, Vitaglione, P, Cuomo, R et al. (2018) Dietary interventions to modulate the gut microbiome – how far away are we from precision medicine. Inflamm Bowel Dis 24, 2142–2154.
16.Vitaglione, P, Morisco, F, Mazzone, G, et al. (2010) Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 52, 1652–1661.
17.Brandt, A, Nier, A, Jin, CJ, et al. (2019) Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: role of intestinal barrier function. Redox Biol 21, 101092.
18.Matsuda, Y, Kobayashi, M, Yamauchi, R, et al. (2011) Coffee and caffeine improve insulin sensitivity and glucose tolerance in C57BL/6J mice fed a high-fat diet. Biosci Biotechnol Biochem 75, 2309–2315.
19.Gregory, KE, Bird, SS, Gross, VS, et al. (2013) Method development for fecal lipidomics profiling. Anal Chem 85, 1114–1123.
20.Bird, SS, Marur, VR, Sniatynski, MJ, et al. (2011) Serum lipidomics profiling using LC-MS and high-energy collisional dissociation fragmentation: focus on triglyceride detection and characterization. Anal Chem 83, 6648–6657.
21.De Filippis, F, Pellegrini, N, Vannini, L, et al. (2016) High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 65, 1812–1821.
22.Caporaso, JG, Kuczynski, J, Stombaugh, J, et al. (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335–336.
23.De Filippis, F, Vannini, L, La Storia, A, et al. (2014) The same microbiota and a potentially discriminant metabolome in the saliva of omnivore, ovo-lacto-vegetarian and vegan individuals. PLOS ONE 9, e112373.
24.Love, MI, Huber, W & Anders, S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550.
25.Souza-Mello, V (2015) Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. World J Hepatol 7, 1012–1019.
26.Salomone, F, Godos, J & Zelber-Sagi, S (2016) Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives. Liver Int 36, 5–20.
27.Reddy, JK & Hashimoto, T (2001) Peroxisomal β-oxidation and peroxisome proliferator-activated receptor R: an adaptive metabolic system. Annu Rev Nutr 21, 193–230.
28.Shimoda, H, Tanaka, J, Kikuchi, M, et al. (2009) Effect of polyphenol-rich extract from walnut on diet-induced hypertriglyceridemia in mice via enhancement of fatty acid oxidation in the liver. J Agric Food Chem 57, 1786–1792.
29.Snyder, SM, Zhao, B, Luo, T, et al. (2016) Consumption of quercetin and quercetin-containing apple and cherry extracts affects blood glucose concentration, hepatic metabolism, and gene expression patterns in obese C57BL/6J high fat-fed mice. J Nutr 146, 1001–1007.
30.Li, AC & Glass, CK (2004) PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res 45, 2161–2173.
31.Boullier, A, Bird, DA, Chang, MK, et al. (2001) Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci 947, 214–223.
32.Vaughan, AM & Oram, JF (2006) ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J Lipid Res 47, 2433–2443.
33.Laffitte, BA, Chao, LC, Li, J, et al. (2003) Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A 100, 5419–5424.
34.Edfalk, S, Steneberg, P & Edlund, H (2008) Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 57, 2280–2287.
35.Lo, CM, King, A, Samuelson, LC, et al. (2010) Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology 138, 1997–2005.
36.Cha, KH, Song, DG, Kim, SM, et al. (2012) Inhibition of gastrointestinal lipolysis by green tea, coffee, and gomchui (Ligularia fischeri) tea polyphenols during simulated digestion. J Agric Food Chem 60, 7152–7157.
37.Murase, T, Yokoi, Y, Misawa, K, et al. (2012) Coffee polyphenols modulate whole-body substrate oxidation and suppress postprandial hyperglycaemia, hyperinsulinaemia and hyperlipidaemia. Br J Nutr 107, 1757–1765.
38.Almoosawi, S, McDougall, GJ & Fyfe, L (2010) Investigating the inhibitory activity of green coffee and cacao bean extracts on pancreatic lipase. Nutr Bull 35, 207–212.
39.O'Donovan, D, Feinle-Bisset, C & Wishart, J (2003) Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects. Br J Nutr 90, 849–852.
40.Guo, Y, Ma, L & Enriori, PJ (2006) Physiological evidence for the involvement of peptide YY in the regulation of energy homeostasis in humans. Obesity (Silver Spring) 14, 1562–1570.
41.Mazzone, G, Lembo, V, D'Argenio, G, et al. (2016) Decaffeinated coffee consumption induces expression of tight junction proteins in high fat diet fed rats. Funct Foods Health Dis 6, 602–611.
42.Cani, PD, Bibiloni, R, Knauf, C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481.
43.Tilg, H, Cani, PD & Mayer, EA (2016) Gut microbiome and liver diseases. Gut 65, 2035–2044.
44.Cani, PD, Amar, J, Iglesias, MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
45.Cani, PD, Possemiers, S, Van de Wiele, T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103.
46.Payne, DW & Talalay, P (1985) Isolation of novel microbial 3α-, 3β-, and 17β-hydroxysteroid dehydrogenases. Purification, characterization, and analytical applications of a 17β-hydroxysteroid dehydrogenase from an Alcaligenes sp. J Biol Chem 260, 13648–13655.
47.Ziganshina, EE, Sharifullina, DM & Lozhkin, AP (2016) Bacterial communities associated with atherosclerotic plaques from Russian individuals with atherosclerosis. PLOS ONE 11, e0164836.
48.Zhou, AL, Hergert, N, Rompato, G, et al. (2015) Whole grain oats improve insulin sensitivity and plasma cholesterol profile and modify gut microbiota composition in C57BL/6J mice. J Nutr 145, 222–230.
49.Morales, FJ, Somoza, V & Fogliano, V (2012) Physiological relevance of dietary melanoidins. Amino Acids 42, 1097–1109.
50.Vitaglione, P, Napolitano, A & Fogliano, V (2008) Cereal dietary fibre: a natural functional ingredient to deliver phenolic compounds into the gut. Trends Food Sci Technol 19, 451–463.
51.Marventano, S, Salomone, F, Godos, J, et al. (2016) Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies. Clin Nutr 35, 1269–1281.